CX Institutional’s Pfizer PFE Stock Holding History

CX Institutional’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.14M	Buy	47,032 +15,797	+51%	+$383K	0.04%	251
2025 Q1	$791K	Sell	31,235 -19,155	-38%	-$485K	0.03%	307
2024 Q4	$1.34M	Buy	50,390 +4,183	+9%	+$111K	0.05%	223
2024 Q3	$1.34M	Buy	46,207 +20,552	+80%	+$595K	0.06%	243
2024 Q2	$718K	Sell	25,655 -24,403	-49%	-$683K	0.03%	325
2024 Q1	$1.39M	Sell	50,058 -59,800	-54%	-$1.66M	0.07%	231
2023 Q4	$3.16M	Buy	109,858 +5,627	+5%	+$162K	0.17%	163
2023 Q3	$3.46M	Buy	104,231 +56,661	+119%	+$1.88M	0.19%	134
2023 Q2	$1.74M	Sell	47,570 -6,940	-13%	-$255K	0.09%	222
2023 Q1	$2.25M	Sell	54,510 -200	-0.4%	-$8.26K	0.12%	207
2022 Q4	$2.8M	Buy	54,710 +10,058	+23%	+$515K	0.17%	165
2022 Q3	$1.95M	Sell	44,652 -56,135	-56%	-$2.46M	0.14%	187
2022 Q2	$5.28M	Buy	100,787 +14,197	+16%	+$744K	0.4%	57
2022 Q1	$4.48M	Sell	86,590 -20,258	-19%	-$1.05M	0.36%	76
2021 Q4	$6.31M	Buy	106,848 +72,378	+210%	+$4.27M	0.5%	52
2021 Q3	$1.48M	Sell	34,470 -31,788	-48%	-$1.37M	0.12%	177
2021 Q2	$2.6M	Buy	66,258 +3,068	+5%	+$120K	0.21%	114
2021 Q1	$2.29M	Sell	63,190 -33,678	-35%	-$1.22M	0.2%	123
2020 Q4	$3.57M	Sell	96,868 -19,190	-17%	-$706K	0.34%	73
2020 Q3	$4.04M	Buy	116,058 +87,814	+311%	+$3.06M	0.44%	61
2020 Q2	$876K	Sell	28,244 -405	-1%	-$12.6K	0.12%	155
2020 Q1	$887K	Buy	28,649 +1,218	+4%	+$37.7K	0.14%	140
2019 Q4	$1.02M	Sell	27,431 -115	-0.4%	-$4.28K	0.18%	110
2019 Q3	$939K	Buy	27,546 +134	+0.5%	+$4.57K	0.15%	134
2019 Q2	$1.13M	Sell	27,412 -3,121	-10%	-$128K	0.18%	120
2019 Q1	$1.23M	Buy	30,533 +5,498	+22%	+$221K	0.22%	117
2018 Q4	$1.04M	Sell	25,035 -14,440	-37%	-$598K	0.22%	85
2018 Q3	$1.65M	Buy	39,475 +1,471	+4%	+$61.5K	0.55%	52
2018 Q2	$1.31M	Buy	+38,004	New	+$1.31M	0.48%	61